Ebola Vaccine Trials May Give Placebo to Those at Risk

As global health officials rush to begin human trials of two promising Ebola vaccines in West African medical workers, a daunting question remains unanswered: Who gets the placebo injection?

To continue reading this article you must be a Bloomberg Professional Service Subscriber.